Advisor Group’s Kiora Pharmaceuticals KPRX Stock Holding History

Advisor Group’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3	Closed	-$3K	–	5347
2019 Q2	$3K	Sell	3 -1	-25%	-$1.48K	﹤0.01%	4865
2019 Q1	$6K	Buy	+4	New	+$9.72K	﹤0.01%	4597

Other funds holding KPRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Advisor Group's KPRX Position: Q3 2019 in Review

Advisor Group sold out of Kiora Pharmaceuticals (KPRX) in Q3 2019, closing a stake of 3 shares — an estimated $3K sold.

Advisor Group first reported a position in KPRX in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2019. 9 funds tracked by Wall St. Rank hold KPRX as of Q3 2019.

Advisor Group reported no remaining Kiora Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Advisor Group sold 3 Kiora Pharmaceuticals shares in Q3 2019, an estimated $3K.
Advisor Group first reported a position in Kiora Pharmaceuticals in Q1 2019 and held it in 2 quarters.
Advisor Group's Kiora Pharmaceuticals position peaked at $6K in Q1 2019.
9 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.